GUT SWELLING AND INJURY REPAIR
Bowel swelling eased in mice; what does that tell you about KLOW peptide?
Researchers measured damage and healing with KPV, GHK-Cu, BPC-157 and TB-500 given separately. The findings explain why scientists are interested, with human benefits still in doubt.
The short answer about healing
Bowel swelling and injured tissue improved in animal and cell tests. The researchers tested individual ingredients, rather than the complete KLOW peptide mixture.
KLOW combines four peptides, small pieces of protein, in one vial. KPV reduced inflammation, the swelling and irritation that can follow injury.
GHK-Cu helped cells make materials needed to repair skin and tissue. BPC-157 has a 15-amino-acid chain, meaning linked parts of protein, and helped rodent tendons and bowels heal.
A tendon joins muscle to bone and helps move a joint. Your own tendon still needs human evidence before a rat's result can answer a treatment question.
For wound and muscle repair, scientists mostly tested the full protein thymosin beta-4. TB-500 contains only a short lab-made portion, so your question about the shorter ingredient still needs proof from experiments that test the shorter ingredient rather than assuming the forms work alike.
The powder dissolves into one liquid containing all four ingredients. The ingredients keep their chemical identities, much as salt and sugar do when both dissolve in water.
Researchers haven't compared the full mixture with another treatment in animals or people. Claims about combined healing therefore borrow from separate ingredient tests, usually using rodents or cells kept alive on lab dishes, and leave you without a measured result for the mixture.
FDA, the agency that approves medicines, hasn't approved KLOW for treatment. The effects page covers safety concerns and reports of relief; weight loss and blood-sugar benefits aren't established.
KLOW peptide blend: how the parts might help repair
The commonly described vial contains 80 mg of freeze-dried powder. The amounts are GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg.
Milligrams measure the powder's weight, as they do for many medicines. These are vial contents, not a tested amount for your treatment.
Water dissolves the powder and lets the four ingredients share one liquid. The ingredients don't join to form a single new substance.
KLOW has no registered drug name or agreed standard for human treatment, and FDA hasn't approved a KLOW medicine even though the mixture is supplied for research. Research supply doesn't establish a treatment for you.
Separate experiments suggest several ways the ingredients might help injured tissue. Researchers still need to measure what happens when the ingredients are combined.
In bowel and immune cells, KPV reduced substances that stir up inflammation. Cells lining an inflamed bowel took KPV inside especially readily.
GHK-Cu helped cells produce collagen, the protein that gives tissue strength. The copper in GHK-Cu also helps join collagen strands during repair.
BPC-157 affected the growth of blood vessels, which bring blood to injured tissue. The tests suggest a reason for the healing seen in animals.
TB-500 holds a protein that cells use when moving into a wound. That action may help skin cells spread across damaged skin.
Less swelling, stronger tissue, more blood, and moving cells could all aid repair. Having reasons to study a mixture doesn't establish that the mixture heals an injury.
You may hear claims that each ingredient makes the others work better. Nobody has measured that claimed benefit in an animal or human comparison of this mixture, so your questions about combined effects remain unanswered.
KLOW peptide blend: what eased bowel trouble in mice
Mice with inflamed bowels had milder disease after swallowing KPV [3]. Cells grown in the lab also released fewer substances that cause inflammation.
The natural hormone behind KPV is made from linked protein parts, which scientists number. KPV comes from the last parts, numbered 11–13; that description tells you where KPV comes from, while the treatment tests tell you what happened to the bowels.
Very small amounts of KPV quieted inflammation in bowel and immune cells [3]. A protein in those cells carries KPV from the surrounding liquid inside.
That protein can only carry KPV at a limited pace. At about 160 micromolar, a measure of KPV dissolved in liquid, the protein carried KPV at half its highest pace [3].
The lab number tells researchers how readily cells take KPV inside. The test measured entry into cells, rather than healing or comfort in people.
A 2008 study found less inflammation in animals' belly lining [9]. KPV appeared to reduce the action of an inflammation-causing substance more directly than other pieces of the same hormone.
Other mouse bowel experiments found earlier recovery and less inflammation [10]. KPV worked even when mice lacked a protein that normally lets the parent hormone affect cells.
That result suggests KPV needn't act exactly like its parent hormone. Scientists still have to establish which actions matter for your bowel trouble.
In 2024, mice received KPV with tacrolimus, a drug that slows the immune system [12]. The researchers packed both into tiny particles designed to enter inflamed bowel cells.
The particle treatment improved the bowel lining and reduced inflammation more than either ingredient alone in that experiment, using mice with both brief bouts and lasting bowel inflammation. The measured gain concerned the mice receiving treatment.
These experiments haven't led to an approved KPV treatment. Published studies also haven't tested KPV's effects throughout a person's body.
What improved in skin, cut tendons, and open wounds
GHK-Cu helped cells make tissue stronger. Cells grown in the lab produced more collagen and other repair materials.
Most of the mixture's powder weight comes from GHK-Cu, which carries copper into the body along with the peptide. That share makes copper handling one of your safety questions.
Blood fluid holds about 200 nanograms per milliliter of GHK-Cu at age 20. The level falls to about 80 nanograms per milliliter at age 60 [4].
A nanogram is a billionth of a gram; a milliliter measures liquid. The age-related decline doesn't establish that replacing GHK-Cu would help your health.
Researchers checked how much cells used their protein-making genes, the instructions in DNA. About 31% showed a 50%-or-greater change in activity, with some becoming busier and others quieter [5].
The changes involved tissue repair, cell protection, and waste removal. These were measures inside cells, rather than people reporting that an injury healed.
In a 2025 rodent bowel study, tissue damage fell and the lining recovered [13]. The bowel result gives a clearer measure of repair than a change in gene activity alone.
BPC-157 helped rats heal a completely cut tendon. The longer name, Body Protection Compound 157, doesn't establish protection for you.
Different rat groups received different amounts of BPC-157: 10 micrograms, 10 nanograms, or 10 picograms per rat [2]. Each amount helped; tendon cells grown outside the rats also spread outward.
Those weights run from millionths to trillionths of a gram. Researchers also linked the ingredient to new blood vessels and changes in blood flow.
Two healthy volunteers received BPC-157 by vein drip in a 2025 test, up to 20 mg [6]. The researchers reported no harm and no measurable changes in blood sugar or tests of the heart, thyroid, liver, and kidneys.
You cannot establish general safety from two people receiving the ingredient. That small safety test also didn't measure healing of an injury.
Thymosin beta-4 helped rat wounds grow new skin. Thymosin beta-4 contains a 43-amino-acid chain, meaning linked protein parts, rather than just the short TB-500 piece.
New skin coverage exceeded salt-water treatment by 42% at 4 days. The gain reached up to 61% at 7 days [1].
Researchers applied the protein to wounds or injected it inside the belly. Most wound evidence concerns thymosin beta-4, so TB-500 needs separate proof of its own.
A 2024 review described how thymosin beta-4 helps inflammation end [11]. Your question about TB-500 wound healing depends on which form researchers actually tested.
What remains unknown after ingredients are mixed
Researchers haven't compared KLOW with single ingredients or smaller mixtures. There's also no comparison with a placebo, a treatment containing no tested ingredient, used to check whether real treatment helps.
You therefore cannot tell whether the mixture adds to the separate benefits. A test has to measure that difference before anyone can promise extra healing for your injury.
The body removes the ingredients at different speeds after treatment. KPV and GHK-Cu clear faster than the larger ingredient, which also leaves quickly.
Tests found that half the BPC-157 cleared in under about 30 minutes. The short TB-500 piece and longer thymosin beta-4 also have different times in the body, without enough evidence here to tell you how much faster either leaves.
A single mixed shot can't hold equal blood levels of every ingredient together. How those changing levels affect healing and harm remains unmeasured.
KLOW research explains what individual experiments measured. KLOW effects covers reported relief and the safety concerns behind your next questions.